Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07754045 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutide Plus Placebo in Older Obese Adults

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Lumos Pharma
8 trials monitored
See all monitored trials
Obesity
3,874 trials monitored
See 152 trials at risk
This is a phase 2 randomized, double-blind, placebo-controlled, multi-center study evaluating the efficacy and safety of LUM-201 plus Semaglutide versus Semaglutide plus placebo in obese adults with body mass index between 30 and 45 kg/m\^2, between the ages of 60 and 85 years that have mild functional impairment.
Trial Details
NCT Number NCT07754045
Lead Sponsor Lumos Pharma
Conditions
(from sponsor)		 Obesity & Overweight
Related terms Obesity, Overweight
Enrollment 202 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov